Prednicarbate
From Wikipedia, the free encyclopedia
Prednicarbate
|
|
Systematic (IUPAC) name | |
[2-(17-ethoxycarbonyloxy-11-hydroxy- 10,13-dimethyl-3-oxo- 7,8,9,11,12,14,15,16- octahydro- 6H-cyclopenta[a]phenanthren-17-yl)- 2-oxo-ethyl] propanoate | |
Identifiers | |
CAS number | |
ATC code | D07 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C27H36O8 |
Mol. mass | 488.57 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | Topical |
Prednicarbate is a relatively new topical corticosteroid drug. It is similar in potency to hydrocortisone. Compared to other topical corticosteroids, like betamethasone, repeated prednicarbate use does not cause skin atrophy as quickly. Corticosteroids have always been an important part of the pharmacological arsenal of dermatology; however, their tendency to produce side-effects has caused the need to search for new preparations.